- Trials with a EudraCT protocol (621)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (25)
621 result(s) found for: Metabolite.
Displaying page 1 of 32.
EudraCT Number: 2007-003114-34 | Sponsor Protocol Number: CUR001 | Start Date*: 2007-11-29 |
Sponsor Name:Department of Nephrology and Renal Transplantation, University Hospitals Leuven | ||
Full Title: The impact of oral curcumin (Curcuma longa) on mycophenolic acid and metabolite pharmacokinetics in stable renal allograft recipients: exploratory investigation of the role of intestinal uridine-di... | ||
Medical condition: Stable renal allograft recipients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-000788-98 | Sponsor Protocol Number: D5320C00001 | Start Date*: 2013-06-18 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females with Polycystic Ovary ... | |||||||||||||
Medical condition: Polycystic Ovary Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001243-12 | Sponsor Protocol Number: H7T-MC-TACX | Start Date*: 2017-04-05 |
Sponsor Name:Eli Lilly and Company Limited | ||
Full Title: An Open-Label, Dose-Ranging Study of Prasugrel in Pediatric Patients With Sickle Cell Disease | ||
Medical condition: sickle cell disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2013-002274-41 | Sponsor Protocol Number: MCL-metoprolol-CR | Start Date*: 2013-07-11 |
Sponsor Name:Medisch Centrum Leeuwaarden | ||
Full Title: The effect of Roux-en-Y gastric bypass on the rate and extent of absorption of metoprolol from a controlled release tablet in female bariatric patient volunteers: a single oral dose study before an... | ||
Medical condition: Roux-en-Y gastric bypass | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002260-10 | Sponsor Protocol Number: MCL-metoprolol-IR | Start Date*: 2013-07-11 |
Sponsor Name:Medisch Centrum Leeuwarden | ||
Full Title: The effect of Roux-en-Y gastric bypass on the rate and extent of absorption of metoprolol from an immediate release tablet in female bariatric patient volunteers: a single oral dose study before an... | ||
Medical condition: Roux-en-Y gastric bypass | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004058-20 | Sponsor Protocol Number: SPD422-203 | Start Date*: 2006-07-06 |
Sponsor Name:Shire Pharmaceutical Development Limited | ||
Full Title: A phase II, open-label, multicentre, pharmacokinetic, pharmacodynamic and safety study of anagrelide hydrochloride in young (18-50 years) and elderly (≥ 65 years) patients with essential thrombocyt... | ||
Medical condition: Xagrid is an antineoplasic indicated for the reduction of elevated platelet counts in at risk essential thrombocythaemia patients who are intolerant to their current therapy or whose elevated plate... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) ES (Completed) SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-015895-87 | Sponsor Protocol Number: Fuijkschot | Start Date*: 2009-12-23 |
Sponsor Name:UMC St Radboud | ||
Full Title: Application of zileuton (Zyflo CR) in patients with Sjögren Larsson Syndrome | ||
Medical condition: Sjögren Larsson syndrome (SLS) is an autosomal recessive inherited neurometabolic disorder which is characterized by a clinical triad of congenital ichthyosis, spastic di- or tetraplegia and mental... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004299-19 | Sponsor Protocol Number: 1A/8655-5 | Start Date*: 2005-10-26 |
Sponsor Name:University Hospital Ostrava | ||
Full Title: New Possibilities of TDM of Cyclosporine A and its metabolites after kidney transplantation | ||
Medical condition: patient on standart immunusupresive therapy with cyclosporine A after renal transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004852-77 | Sponsor Protocol Number: GO29642 | Start Date*: 2015-05-27 | |||||||||||
Sponsor Name:Genentech, Inc | |||||||||||||
Full Title: AN OPEN-LABEL, PHASE I/IIA STUDY OF GDC-0810 IN POSTMENOPAUSAL WOMEN WITH LOCALLY ADVANCED OR METASTATIC ESTROGEN RECEPTOR POSITIVE BREAST CANCER | |||||||||||||
Medical condition: Patients with locally advanced or metastatic estrogen receptor (ER) positive breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002754-74 | Sponsor Protocol Number: 67896062PAH1013 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ACTELION Pharmacteuticals Ltd. | |||||||||||||
Full Title: A multicenter, open-label, single-arm study to assess the pharmacokinetics and safety of macitentan in children aged 1 month to <2 years with pulmonary arterial hypertension | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003417-19 | Sponsor Protocol Number: BN42644 | Start Date*: 2022-01-03 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:F. HOFFMANN - LA ROCHE LTD. | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A TWO-PART, SEAMLESS, MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND EFFICACY OF RO7204239 IN COMBI... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Spinal Muscular Atrophy (SMA) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) PL (Ongoing) DE (Ongoing) BE (Ongoing) NL (Ongoing) ES (Ongoing) PT (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001723-10 | Sponsor Protocol Number: 767905/012 | Start Date*: 2005-08-26 |
Sponsor Name:GlaxoSmithKline R & D Limited | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of O... | ||
Medical condition: Opioid-induced bowel dysfunction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) FI (Completed) GB (Completed) DE (Completed) DK (Completed) EE (Completed) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002671-26 | Sponsor Protocol Number: 9113 | Start Date*: 2017-12-19 | |||||||||||
Sponsor Name:Isala | |||||||||||||
Full Title: The effect of Opioids on P2Y12 Receptor Inhibition in patients with ST-Elevation Myocardial Infarction who are pre-treated with crushed Ticagrelor | |||||||||||||
Medical condition: Acute Coronary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000537-24 | Sponsor Protocol Number: IIS-HEPA-TEST | Start Date*: 2014-07-16 |
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
Full Title: Pilot clinical trial phase I / IIa to determine condition, low dose and effectiveness of liver function tests (Hepatotest) | ||
Medical condition: Hepatic Function. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003195-11 | Sponsor Protocol Number: CS0917-A-E-107 | Start Date*: 2005-01-20 |
Sponsor Name:Sankyo Pharma GmbH | ||
Full Title: The effect of the co-administration of multiple oral doses of the fructose-1,6-bisphosphatase (FBPase) inhibitor CS-917 and glibenclamide on pharmacokinetics, safety and tolerability in diabetic pa... | ||
Medical condition: Diabetes mellitus type 2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000134-22 | Sponsor Protocol Number: MDCO-CAN-15-01 | Start Date*: 2021-01-14 |
Sponsor Name:Chiesi Farmaceutici S.p.A. | ||
Full Title: A Prospective, Open-Label, Single-Arm, Multi-Center Study to Assess The Pharmacokinetics/Pharmacodynamics (PK/PD) AND Safety Of Different Cangrelor Doses In Neonatal Subjects At Risk Of Thrombosis. | ||
Medical condition: Postoperative neonatal cardiac subjects who are undergoing surgery for placement of systemic-to pulmonary artery palliative shunts (e.g., Blalock-Taussig or central shunt), right ventricle to pulmo... | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2019-004979-39 | Sponsor Protocol Number: MSP-2017-1220 | Start Date*: 2020-08-06 |
Sponsor Name:Milestone Pharmaceuticals Inc. | ||
Full Title: An open-label, mass balance study to investigate the absorption, distribution, metabolism and excretion of [14C]-etripamil nasal spray after a single dose to healthy male subjects | ||
Medical condition: Paroxysmal supraventricular tachycardia (PSVT) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001041-83 | Sponsor Protocol Number: FKC-009 | Start Date*: 2015-04-13 | |||||||||||
Sponsor Name:Astellas Pharma Canada Inc. | |||||||||||||
Full Title: Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de novo Cardiac Transplant: A Comparison between Tacrolimus- and Cyclosporine- based Im... | |||||||||||||
Medical condition: Cardiac transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001181-15 | Sponsor Protocol Number: FIS-002-2019 | Start Date*: 2019-09-17 | |||||||||||
Sponsor Name:Fulcrum Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 24-Week, Parallel-Group Study of the Efficacy and Safety of Losmapimod in Treating Subjects with Facioscapulohumeral Muscular Dystrophy (FSHD) | |||||||||||||
Medical condition: Facioscapulohumeral Muscular Dystrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005159-15 | Sponsor Protocol Number: DORI-NOS-1008 | Start Date*: 2012-03-05 |
Sponsor Name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | ||
Full Title: An Open-Label, Parallel-Group Study to Evaluate the Single-Dose Pharmacokinetics and Safety of Doripenem in Pediatric Patients 3 Months to 17 Years of Age, Inclusive | ||
Medical condition: Bacterial infections | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.